SCHEMBL26435698

SCHEMBL26435698

c1ccc2c(c1)ccc1cccc(-c3ccc(-c4nc(-c5ccc6c(c5)sc5ccccc56)nc(-c5cccc6oc7ccccc7c56)n4)cc3)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
BACE1 P56817 1/20 0.33
ABCG2 Q9UNQ0 4/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
RAB9A P51151 1/20 0.32
F9 P00740 1/20 0.31
ALOX5 P09917 1/20 0.31
PRKDC P78527 1/20 0.31
KDM4E B2RXH2 1/20 0.30
TP53 P04637 1/20 0.30
TSHR P16473 1/20 0.30
NFKB1 P19838 1/20 0.30
MAPK1 P28482 1/20 0.30
NFKB2 Q00653 1/20 0.30
RELA Q04206 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435351 1.00 TDP1 (0.36) TDP1L3MBTL1BACE1ABCG2ALDH1A1
SCHEMBL26435524 0.94 TDP1 (0.34) TDP1L3MBTL1ABCG2ALDH1A1MAPT
SCHEMBL26435395 0.94 TDP1 (0.34) TDP1L3MBTL1BACE1ABCG2ALDH1A1
SCHEMBL24930793 0.93 TDP1 (0.37) TDP1L3MBTL1ABCG2ALDH1A1MAPT
SCHEMBL26435202 0.92 L3MBTL1 (0.35) TDP1L3MBTL1ABCG2ALDH1A1MAPT
SCHEMBL26435700 0.92 TDP1 (0.35) TDP1L3MBTL1BACE1ABCG2ALDH1A1
SCHEMBL26435444 0.92 TDP1 (0.35) TDP1L3MBTL1BACE1ABCG2ALDH1A1
SCHEMBL26435347 0.91 PRKDC (0.34) TDP1L3MBTL1ABCG2ALDH1A1MAPT
SCHEMBL23820443 0.91 PRKDC (0.36) TDP1L3MBTL1BACE1ALDH1A1MAPT
SCHEMBL26434981 0.91 ALOX5 (0.40) TDP1L3MBTL1ABCG2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 TDP1 1017/4885L3MBTL1 1536/4885BACE1 3468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.